Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires

Autores
Recondo, Gonzalo; Cosacow, César; Cutuli, Hernán Javier; Cermignani, Luciano; Straminsky, Samanta; Naveira, Martin; Pitzzu, Martin; De Ronato, Gabriela; Nacuzzi, Gabriela; Taetti, Gonzalo; Corsico, Santiago; Berrueta, Mabel; Colucci, Giuliana; Gibbons, Luz; Gutierrez, Laura; García Elorrio, Ezequiel
Año de publicación
2019
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Objectives: Describe the time elapsed from the diagnosis to treatment with chemotherapy for patients with breast and lung cancer at public and private hospitals in Buenos Aires. Design: Retrospective cohort study. Setting: Three public and three private academic hospitals in Buenos Aires. Participants: Patients with breast (n = 168) or lung cancer (n = 100) diagnosis treated with chemotherapy. Main outcomes measures: Clinical and sociodemographic data were collected in a stratified sample. We used the Kaplan–Meier estimator to analyse the time elapsed and the log rank test to compare both groups Results: For breast cancer patients, median time elapsed between diagnosis and treatment with chemotherapy was 76 days (95% CI: 64–86) in public and 60 days (95% CI: 52–65) in private hospitals (P = 0.0001). For adjuvant and neoadjuvant treatments, median time was 130 (95% CI: 109–159) versus 64 (95% CI: 56–73) days (P < 0.0001) and 57 days (95% CI: 49–75) versus 26 (95% CI: 16–41) days, respectively (P = 0.0002). There were no significant differences in the time from first consultation to diagnosis. In patients with lung cancer, median time from diagnosis to treatment was 71 days (95% CI: 60–83) in public hospitals and 31 days (95% CI: 24–39) in private hospitals (P = 0.0002). In the metastatic setting, median time to treatment was 63 days (95% CI: 45–83) in public and 33 (95% CI: 26–44) days in private hospitals (P = 0.005). Conclusions: There are significant disparity in the access to treatment with chemotherapy for patients in Buenos Aires, Argentina.
Fil: Recondo, Gonzalo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina
Fil: Cosacow, César. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: Cutuli, Hernán Javier. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Fil: Cermignani, Luciano. Hospital Alemán; Argentina
Fil: Straminsky, Samanta. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina
Fil: Naveira, Martin. Hospital Británico de Buenos Aires; Argentina
Fil: Pitzzu, Martin. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Agudos Carlos Durand; Argentina
Fil: De Ronato, Gabriela. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina
Fil: Nacuzzi, Gabriela. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Agudos Carlos Durand; Argentina
Fil: Taetti, Gonzalo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Fil: Corsico, Santiago. Hospital Británico de Buenos Aires; Argentina
Fil: Berrueta, Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Colucci, Giuliana. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: Gibbons, Luz. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: Gutierrez, Laura. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: García Elorrio, Ezequiel. Centro de Educación Medica E Invest.clinicas; Argentina
Materia
ACCESS
ARGENTINA
BREAST CANCER
CHEMOTHERAPY
LUNG CANCER
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/147930
Acceder
id CONICETDig_9971ab7a0edc47ea73f6dcde6e88583e
oai_identifier_str oai:ri.conicet.gov.ar:11336/147930
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos AiresRecondo, GonzaloCosacow, CésarCutuli, Hernán JavierCermignani, LucianoStraminsky, SamantaNaveira, MartinPitzzu, MartinDe Ronato, GabrielaNacuzzi, GabrielaTaetti, GonzaloCorsico, SantiagoBerrueta, MabelColucci, GiulianaGibbons, LuzGutierrez, LauraGarcía Elorrio, EzequielACCESSARGENTINABREAST CANCERCHEMOTHERAPYLUNG CANCERhttps://purl.org/becyt/ford/3.2https://purl.org/becyt/ford/3Objectives: Describe the time elapsed from the diagnosis to treatment with chemotherapy for patients with breast and lung cancer at public and private hospitals in Buenos Aires. Design: Retrospective cohort study. Setting: Three public and three private academic hospitals in Buenos Aires. Participants: Patients with breast (n = 168) or lung cancer (n = 100) diagnosis treated with chemotherapy. Main outcomes measures: Clinical and sociodemographic data were collected in a stratified sample. We used the Kaplan–Meier estimator to analyse the time elapsed and the log rank test to compare both groups Results: For breast cancer patients, median time elapsed between diagnosis and treatment with chemotherapy was 76 days (95% CI: 64–86) in public and 60 days (95% CI: 52–65) in private hospitals (P = 0.0001). For adjuvant and neoadjuvant treatments, median time was 130 (95% CI: 109–159) versus 64 (95% CI: 56–73) days (P < 0.0001) and 57 days (95% CI: 49–75) versus 26 (95% CI: 16–41) days, respectively (P = 0.0002). There were no significant differences in the time from first consultation to diagnosis. In patients with lung cancer, median time from diagnosis to treatment was 71 days (95% CI: 60–83) in public hospitals and 31 days (95% CI: 24–39) in private hospitals (P = 0.0002). In the metastatic setting, median time to treatment was 63 days (95% CI: 45–83) in public and 33 (95% CI: 26–44) days in private hospitals (P = 0.005). Conclusions: There are significant disparity in the access to treatment with chemotherapy for patients in Buenos Aires, Argentina.Fil: Recondo, Gonzalo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; ArgentinaFil: Cosacow, César. Centro de Educación Medica E Invest.clinicas; ArgentinaFil: Cutuli, Hernán Javier. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaFil: Cermignani, Luciano. Hospital Alemán; ArgentinaFil: Straminsky, Samanta. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; ArgentinaFil: Naveira, Martin. Hospital Británico de Buenos Aires; ArgentinaFil: Pitzzu, Martin. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Agudos Carlos Durand; ArgentinaFil: De Ronato, Gabriela. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; ArgentinaFil: Nacuzzi, Gabriela. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Agudos Carlos Durand; ArgentinaFil: Taetti, Gonzalo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; ArgentinaFil: Corsico, Santiago. Hospital Británico de Buenos Aires; ArgentinaFil: Berrueta, Mabel. Instituto de Efectividad Clínica y Sanitaria; ArgentinaFil: Colucci, Giuliana. Centro de Educación Medica E Invest.clinicas; ArgentinaFil: Gibbons, Luz. Centro de Educación Medica E Invest.clinicas; ArgentinaFil: Gutierrez, Laura. Centro de Educación Medica E Invest.clinicas; ArgentinaFil: García Elorrio, Ezequiel. Centro de Educación Medica E Invest.clinicas; ArgentinaOxford University Press2019-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/vnd.openxmlformats-officedocument.wordprocessingml.documentapplication/pdfhttp://hdl.handle.net/11336/147930Recondo, Gonzalo; Cosacow, César; Cutuli, Hernán Javier; Cermignani, Luciano; Straminsky, Samanta; et al.; Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires; Oxford University Press; International Journal For Quality In Health Care; 31; 9; 5-2019; 682-6901353-4505CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1093/intqhc/mzz047info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-10-15T14:22:45Zoai:ri.conicet.gov.ar:11336/147930instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-10-15 14:22:45.382CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
title Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
spellingShingle Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
Recondo, Gonzalo
ACCESS
ARGENTINA
BREAST CANCER
CHEMOTHERAPY
LUNG CANCER
title_short Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
title_full Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
title_fullStr Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
title_full_unstemmed Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
title_sort Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires
dc.creator.none.fl_str_mv Recondo, Gonzalo
Cosacow, César
Cutuli, Hernán Javier
Cermignani, Luciano
Straminsky, Samanta
Naveira, Martin
Pitzzu, Martin
De Ronato, Gabriela
Nacuzzi, Gabriela
Taetti, Gonzalo
Corsico, Santiago
Berrueta, Mabel
Colucci, Giuliana
Gibbons, Luz
Gutierrez, Laura
García Elorrio, Ezequiel
author Recondo, Gonzalo
author_facet Recondo, Gonzalo
Cosacow, César
Cutuli, Hernán Javier
Cermignani, Luciano
Straminsky, Samanta
Naveira, Martin
Pitzzu, Martin
De Ronato, Gabriela
Nacuzzi, Gabriela
Taetti, Gonzalo
Corsico, Santiago
Berrueta, Mabel
Colucci, Giuliana
Gibbons, Luz
Gutierrez, Laura
García Elorrio, Ezequiel
author_role author
author2 Cosacow, César
Cutuli, Hernán Javier
Cermignani, Luciano
Straminsky, Samanta
Naveira, Martin
Pitzzu, Martin
De Ronato, Gabriela
Nacuzzi, Gabriela
Taetti, Gonzalo
Corsico, Santiago
Berrueta, Mabel
Colucci, Giuliana
Gibbons, Luz
Gutierrez, Laura
García Elorrio, Ezequiel
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv ACCESS
ARGENTINA
BREAST CANCER
CHEMOTHERAPY
LUNG CANCER
topic ACCESS
ARGENTINA
BREAST CANCER
CHEMOTHERAPY
LUNG CANCER
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.2
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Objectives: Describe the time elapsed from the diagnosis to treatment with chemotherapy for patients with breast and lung cancer at public and private hospitals in Buenos Aires. Design: Retrospective cohort study. Setting: Three public and three private academic hospitals in Buenos Aires. Participants: Patients with breast (n = 168) or lung cancer (n = 100) diagnosis treated with chemotherapy. Main outcomes measures: Clinical and sociodemographic data were collected in a stratified sample. We used the Kaplan–Meier estimator to analyse the time elapsed and the log rank test to compare both groups Results: For breast cancer patients, median time elapsed between diagnosis and treatment with chemotherapy was 76 days (95% CI: 64–86) in public and 60 days (95% CI: 52–65) in private hospitals (P = 0.0001). For adjuvant and neoadjuvant treatments, median time was 130 (95% CI: 109–159) versus 64 (95% CI: 56–73) days (P < 0.0001) and 57 days (95% CI: 49–75) versus 26 (95% CI: 16–41) days, respectively (P = 0.0002). There were no significant differences in the time from first consultation to diagnosis. In patients with lung cancer, median time from diagnosis to treatment was 71 days (95% CI: 60–83) in public hospitals and 31 days (95% CI: 24–39) in private hospitals (P = 0.0002). In the metastatic setting, median time to treatment was 63 days (95% CI: 45–83) in public and 33 (95% CI: 26–44) days in private hospitals (P = 0.005). Conclusions: There are significant disparity in the access to treatment with chemotherapy for patients in Buenos Aires, Argentina.
Fil: Recondo, Gonzalo. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Parque Centenario. CEMIC-CONICET. Centro de Educaciones Médicas e Investigaciones Clínicas "Norberto Quirno". CEMIC-CONICET; Argentina
Fil: Cosacow, César. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: Cutuli, Hernán Javier. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Fil: Cermignani, Luciano. Hospital Alemán; Argentina
Fil: Straminsky, Samanta. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina
Fil: Naveira, Martin. Hospital Británico de Buenos Aires; Argentina
Fil: Pitzzu, Martin. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Agudos Carlos Durand; Argentina
Fil: De Ronato, Gabriela. Gobierno de la Ciudad de Buenos Aires. Hospital General de Agudos "Juan A. Fernández"; Argentina
Fil: Nacuzzi, Gabriela. Gobierno de la Ciudad Autónoma de Buenos Aires. Hospital General de Agudos Carlos Durand; Argentina
Fil: Taetti, Gonzalo. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Oncología "Ángel H. Roffo"; Argentina
Fil: Corsico, Santiago. Hospital Británico de Buenos Aires; Argentina
Fil: Berrueta, Mabel. Instituto de Efectividad Clínica y Sanitaria; Argentina
Fil: Colucci, Giuliana. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: Gibbons, Luz. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: Gutierrez, Laura. Centro de Educación Medica E Invest.clinicas; Argentina
Fil: García Elorrio, Ezequiel. Centro de Educación Medica E Invest.clinicas; Argentina
description Objectives: Describe the time elapsed from the diagnosis to treatment with chemotherapy for patients with breast and lung cancer at public and private hospitals in Buenos Aires. Design: Retrospective cohort study. Setting: Three public and three private academic hospitals in Buenos Aires. Participants: Patients with breast (n = 168) or lung cancer (n = 100) diagnosis treated with chemotherapy. Main outcomes measures: Clinical and sociodemographic data were collected in a stratified sample. We used the Kaplan–Meier estimator to analyse the time elapsed and the log rank test to compare both groups Results: For breast cancer patients, median time elapsed between diagnosis and treatment with chemotherapy was 76 days (95% CI: 64–86) in public and 60 days (95% CI: 52–65) in private hospitals (P = 0.0001). For adjuvant and neoadjuvant treatments, median time was 130 (95% CI: 109–159) versus 64 (95% CI: 56–73) days (P < 0.0001) and 57 days (95% CI: 49–75) versus 26 (95% CI: 16–41) days, respectively (P = 0.0002). There were no significant differences in the time from first consultation to diagnosis. In patients with lung cancer, median time from diagnosis to treatment was 71 days (95% CI: 60–83) in public hospitals and 31 days (95% CI: 24–39) in private hospitals (P = 0.0002). In the metastatic setting, median time to treatment was 63 days (95% CI: 45–83) in public and 33 (95% CI: 26–44) days in private hospitals (P = 0.005). Conclusions: There are significant disparity in the access to treatment with chemotherapy for patients in Buenos Aires, Argentina.
publishDate 2019
dc.date.none.fl_str_mv 2019-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/147930
Recondo, Gonzalo; Cosacow, César; Cutuli, Hernán Javier; Cermignani, Luciano; Straminsky, Samanta; et al.; Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires; Oxford University Press; International Journal For Quality In Health Care; 31; 9; 5-2019; 682-690
1353-4505
CONICET Digital
CONICET
url http://hdl.handle.net/11336/147930
identifier_str_mv Recondo, Gonzalo; Cosacow, César; Cutuli, Hernán Javier; Cermignani, Luciano; Straminsky, Samanta; et al.; Access of patients with breast and lung cancer to chemotherapy treatment in public and private hospitals in the city of Buenos Aires; Oxford University Press; International Journal For Quality In Health Care; 31; 9; 5-2019; 682-690
1353-4505
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1093/intqhc/mzz047
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/vnd.openxmlformats-officedocument.wordprocessingml.document
application/pdf
dc.publisher.none.fl_str_mv Oxford University Press
publisher.none.fl_str_mv Oxford University Press
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1846082628571103232
score 13.22299

Publicaciones similares